330 likes | 663 Vues
Objectives. Participants will be able to:describe the clinical signs and symptoms of alcohol and sedative withdrawal describe the neurobiology of alcohol withdrawaldescribe the clinical methods used to manage alcohol and sedative drug detoxification. sedativesalcohol, alprazolamstimulantscocaine, amphetamines, nicotineopiatesheroin, methadone, morphine.
E N D
1: Medical Detoxification
2: Objectives Participants will be able to:
describe the clinical signs and symptoms of alcohol and sedative withdrawal
describe the neurobiology of alcohol withdrawal
describe the clinical methods used to manage alcohol and sedative drug detoxification
3: sedatives alcohol, alprazolam
stimulants cocaine, amphetamines, nicotine
opiates heroin, methadone, morphine Medical Detoxification
4: Assess for Risk of Alcohol Withdrawal History of DTs
Daily use of alcohol (more than 12 drinks per day)
History of morning drinking
Prior treatment for alcohol problems
5: Outpatient versus Inpatient Treatment Medical criteria
Absence of serious medical problems
No history of drug withdrawal-induced delirium, seizures, or psychosis
Abstinence criteria
Patient agrees to abstinence and treatment
Patient agrees to random testing
Psychosocial criteria
Patient has support of sober family and friends
6: Pathophysiology of Sedative Withdrawal GABA neurotransmitters
Receptor complexes are primary central nervous system inhibitory sites
Reduces nerve cell excitability
Sedative brain receptors
Specific receptors
Alcohol - no specific receptor
Drug receptor activation
Activation stimulates GABA release
Chronic sedative use depletes GABA
7: General Signs and Symptoms of Alcohol and Sedative Withdrawal Tachycardia
Increased systolic blood pressure
Increased temperature (rule out infection)
Diaphoresis
Anxiety/fear
Insomnia/nightmares
Vomiting/diarrhea
Tremor
8: Stages of Alcohol and Sedative Withdrawal
9: Alcohol/Sedative Withdrawal
10: Clinical Withdrawal Assessment Scale Temperature
Pulse
Respiration
Blood Pressure
Anxiety
Agitation
Tremor Diaphoresis
Eating disturbance
GI distress: nausea, vomiting, diarrhea
Sleep disturbances
Clouding of sensorium
Hallucinations
Convulsions
11: Alcohol and Sedative Withdrawal Not all patients demonstrate all symptoms
Progression from Stage 1 to 2 to 3 is usual
Rapid development of Stage 3 in 12 hours is possible
Treatment may not prevent development of delirium tremens
1/3 of patients with seizures will develop Stage 3
12: Withdrawal from Sedative Hypnotics Other than Alcohol Clinical Characteristics:
Similar to alcohol
Barbiturates - temperature, delirium, seizures
Benzodiazepines - anorexia, insomnia, agitation
Onset:
Alprazolam - 1-2 days
Diazepam, phenobarbital - 5-10 days
13: Treatment Methods for Alcohol/Drug Withdrawal Supportive Care
Nonpharmacological treatment
Three R’s:
Reality
Reassurance
Respect
14: Medication for Sedative Withdrawal Intravenous fluids
ß-blockers
Thiamine
Potassium
Vistaril for nausea
15: Benzodiazepine Treatment for Alcohol and Sedative Withdrawal Rationale
Rapid induction
Easy transition
Adequate control of symptoms
Prevention of Stage 2, 3 withdrawal
Partially protective against seizures
Side effects: over-sedation, aspiration pneumonia, drug dependence
16: Benzodiazepine Treatment: Loading Dose When should treatment be initiated?
Depends on risk factors and symptoms
How much medication should be used?
20-60 mg Diazepam in 3 divided doses orally
Additional treatment:
Diazepam every 2 hours until symptoms are controlled
Tapering unnecessary
17: Treatment Alternatives Chlordiazepoxide
Lorazepam
Oxazepam
Valproic acid Clonidine
Carbamazepine
Chlormethiazole
Phenobarbital
18: Medications no Longer in Widespread Use... Alcohol
Bromides
Paraldehyde
19: Alcohol Withdrawal Seizures Who should receive prophylactic treatment?
Currently on an anticonvulsant
History of epilepsy
History of withdrawal seizures
Magnesium level <1.2 mg %
Prophylactic drug treatment:
Carbamazepine preferred over phenytoin
Medication should be given early
Loading dose: Tegretol 100 mg every 2 hours x 4 doses
After, 200 mg every 6 hours x 7 days
20: Treatment of Delirium Tremens Not Responsive to Valium Lorazepam 2-6 mg. every hour
Haloperidol 1-5 mg. every 2-6 hours
Haldol may decrease seizure threshold
21: Phenobarbital Protocol for Treatment of Sedative Withdrawal Rapid Induction
When compared to Librium (Smith, 1978)
Decreased period of disability
Decreased period of insomnia
Decreased cardiovascular abnormalities
Excellent anticonvulsant
Only side effect is sedation
Abuse potential is minimal
Treatment for polydrug withdrawal
22: Phenobarbital Protocol for Treatment of Sedative Withdrawal Loading and Supplemental (sodium luminal)
130-160 mg. IM as needed
Phenobarbital (routine) orally
30 mg. 4 times a day x 3 days
15 mg. 4 times a day x 2 days
15 mg. twice a day x 1 day
23: Common Characteristics of Cocaine and Amphetamine Withdrawal Depression, insomnia, fatigue, headache
Irritability, poor concentration, and restlessness
REM sleep may be increased for weeks after last use
Intense drug craving
Suicidal ideation is the norm
24: Cocaine Withdrawal: Unique Features Paranoia and acute psychosis
Intense craving and drug-seeking behavior
Severe anhedonia, depression, and suicidal ideation
25: Amphetamine Withdrawal: Unique Features “Amphetamine psychosis” may be difficult to separate from organic illness
Symptoms:
feelings of persecution
paranoia
compulsive behavior
visual or auditory hallucinations
26: Tobacco Withdrawal: Specific Effects Symptoms:
increased appetite
intense craving
drug-seeking behavior irritability
difficulty with concentration
easily fatigued
27: Summary of Clinical Characteristics of Stimulant Withdrawal Amphetamines
Cocaine
Nicotine
28: Drug Treatment for Cocaine and Amphetamine Withdrawal Treatment of agitation/paranoia:
Mellaril 25-50 mg.
Haldol 5 mg. IM/IV
Treatment of cocaine craving:
???
Treatment of depression:
Amitriptyline 50-150 mg. h.s.
29: Grading Scheme for Opioid Withdrawal
30: Drug Treatment for Opiate Withdrawal Clonidine
0.1 mg. test dose
then 0.2 mg. three times a day x 3-5 days, and
#2 clonidine patch for 14 days
Promethazine
25 mg. IM for nausea
Lorazepam
2-4 mg. by mouth or IV for anxiety, restlessness
Ibuprofen
800 mg. for muscle cramps and joint pain
31: Opioid Detoxification Buprenorphine
Indication
Dose
Duration
Side effects
Efficacy
32: Opioid Detoxification Naltrexone
Indication
Dose
Duration
Protocol
Side effects
Efficacy
33: Methadone Patients on methadone maintenance:
Reduce 2-3 mg. per day down to 30 mg.
Then 1-2 mg. per day
Patients dependent on other opioids
10 mg. of methadone as an initial dose
Average 24 hour dose is 20-30 mg.
For detoxification, methadone should be tapered in 7-10 days